News + Filings Holdings
All
13F
13D/G
Other
|
|
Soleus Capital, LLC
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/14/2023 |
SC 13G/A
| Soleus Capital, LLC reports a 8.8% stake in ESSA Pharma Inc. |
| 02/10/2022 |
SC 13G/A
| Soleus Capital, LLC reports a 0% stake in DARIOHEALTH CORP. |
| 02/10/2022 |
SC 13G/A
| Soleus Capital, LLC reports a 8% stake in ESSA Pharma Inc. |
| 02/12/2021 |
SC 13G/A
| Soleus Capital, LLC reports a 10% stake in ESSA Pharma Inc. |
| 08/03/2020 |
SC 13G/A
| Soleus Capital, LLC reports a 10% stake in ESSA Pharma Inc. |
| 07/31/2020 |
SC 13G
| Soleus Capital, LLC reports a 5.6% stake in DARIOHEALTH CORP. |
| 05/15/2020 |
4
| Soleus Private Equity GP I, LLC (10% Owner) has filed a Form 4 on Lyra Therapeutics, Inc.|
Txns:
| Converted 338,330 shares
@ $0
Converted 104,608 shares
@ $0
Sold 16,909 shares
@ $16, valued at
$270.5k
Bought 155,000 shares
@ $16, valued at
$2.5M
Converted 11,666,666 convertible preferred
@ $0
Converted 3,607,224 convertible preferred
@ $0
Exercised (in-or-at-the-money) 31,382 warrants
@ $8.63, valued at
$270.8k
|
|
| 02/12/2020 |
SC 13G/A
| Soleus Capital, LLC reports a 10% stake in ESSA Pharma Inc. |
| 08/29/2019 |
SC 13G
| Soleus Capital, LLC reports a 10% stake in ESSA Pharma Inc. |
|
|